CClinicalTrials.gg
Sign In
CompletedNCT00153309Updated Nov 17, 2005

Program Evaluation of People With Arthritis Can Exercise

A Phase 2/3 interventional study of People with Arthritis Can Exercise in Arthritis, Osteoarthritis and Rheumatoid Arthritis, sponsored by Centers for Disease Control and Prevention. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2005-11-17.

Sponsored by Centers for Disease Control and Prevention · Phase 2/3, Interventional, and Treatment

Phase
Phase 2/3
Study type
Interventional
Enrollment
320
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate the health and arthritis-specific benefits of participation in the Arthritis Foundation People with Arthritis Can Exercise program and to collect information to improve community-based dissemination of this program.

Read the detailed description

Only about 24% of people with arthritis report sufficient physical activity to provide general health benefits. Research has demonstrated that many people with arthritis can safely exercise to improve fitness and health. The People with Arthritis Can Exercise (PACE) program, developed by the Arthritis Foundation, is a land-based recreational physical activity and exercise program. PACE has been offered as a community-based program for over 10 years and small studies have reported benefits for people with arthritis. However, there has been no randomized controlled community trials that evaluate the effectiveness of PACE in the community. The goals of the Evaluation of PACE project are to: (1) appropriately evaluate the AF PACE exercise program, and (2) provide information to support effective content, recruitment and programming. Specific objectives for meeting these goals include:

  1. Identify the theoretical foundations and constructs for evaluating the program and select and use appropriate outcome measures;
  2. Plan and conduct a randomized controlled trial of 8 and 16 week PACE programs;
  3. Perform a qualitative evaluation using focus groups of PACE instructors and participants;
  4. Disseminate findings and make recommendations.
02

Conditions studied

  • Arthritis
  • Osteoarthritis
  • Rheumatoid Arthritis

Browse trials for

Keywords

  • arthritis
  • exercise
  • physical activity
  • physical function
  • pain
03

In context

Arthritis

3,554 studies on the registry are indexed under Arthritis; 317 are open to participants now.

This study's enrollment of 320 is above the median of 90 across 2,377 interventional studies indexed under Arthritis.

Browse Arthritis studies →

Lead sponsor

Centers for Disease Control and Prevention is the lead sponsor of 273 studies on the registry; 2 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 8 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults age 18 and older
  • Self-reported arthritis or chronic joint symptoms
  • Community-dwelling

Exclusion criteria

Exclusion Criteria:

  • Serious medical conditions which would contraindicate exercise
  • No severe physical or mental condition
05

Study design

Phase
Phase 2 / Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
320 participants

Interventions

  • BehavioralPeople with Arthritis Can Exercise
06

What researchers measure

Primary outcomes

  1. Physical Activity Level - PASE instrument at baseline, 8 and 16 weeks.

  2. Pain Visual Analog Scale - at baseline, 8 and 16 weeks

  3. Physical Function using the Functional Fitness Battery at baseline, 8 and 16 weeks

  4. Self-reported function (HAQ) at baseline, 8 and 16 weeks

Secondary outcomes

  1. Health-related quality of life

  2. Disease status

  3. Self-efficacy for arthritis management

  4. Self-efficacy for exercise

  5. Social support

  6. Depressive symptoms

  7. Anxiety

07

Study locations

1 site
  • St. Louis University
    St. Louis, Missouri 63104, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 17, 2005, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00153309
Lead sponsor
Centers for Disease Control and Prevention
Collaborators
University of Missouri-Columbia, St. Louis University
First posted
Sep 12, 2005
Start date
Jun 2003
Completion
Jun 2005
Last update
Nov 17, 2005

Study contacts

Jennifer M Hootman, PhD
study director · Centers for Disease Control and Prevention
Marian Minor, PhD
principal investigator · University of Missouri-Columbia
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2005. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Arthritis→

Other studies from this sponsor

Centers for Disease Control and Prevention

Start the discussion